AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Ardelyx, Inc.
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001WH4F33
3.08▼ 0.12 (-3.75%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
3.20
Day's Range
3.02 – 3.20
52-Week Range
3.02 – 8.40
Volume
4.8M
Avg Volume
4.4M
Share Statistics
Shares Outstanding
Employees
489
Exchange
XNAS
Listed
2014-06-19
Share count as of July 30, 2026

Ardelyx, Inc. (ARDX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Ardelyx, Inc. (ARDX)
What is Ardelyx, Inc.'s Market Cap?
Ardelyx, Inc.'s Market Cap is $767.5M, based on as-reported figures from SEC (XBRL) filings.
What is Ardelyx, Inc.'s Enterprise Value?
Ardelyx, Inc.'s Enterprise Value is $922.1M, based on as-reported figures from SEC (XBRL) filings.
What is Ardelyx, Inc.'s Price / Sales?
Ardelyx, Inc.'s Price / Sales is 1.7×, based on as-reported figures from SEC (XBRL) filings.
What is Ardelyx, Inc.'s EV / Revenue?
Ardelyx, Inc.'s EV / Revenue is 2.0×, based on as-reported figures from SEC (XBRL) filings.
What is Ardelyx, Inc.'s EV / EBITDA?
Ardelyx, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Ardelyx, Inc.'s Revenue (TTM)?
Ardelyx, Inc.'s Revenue (TTM) is $450.9M, based on as-reported figures from SEC (XBRL) filings.
What is Ardelyx, Inc.'s Net Income (TTM)?
Ardelyx, Inc.'s Net Income (TTM) is -$55.7M, based on as-reported figures from SEC (XBRL) filings.
What is Ardelyx, Inc.'s EBITDA?
Ardelyx, Inc.'s EBITDA is -$32.1M, based on as-reported figures from SEC (XBRL) filings.
What is Ardelyx, Inc.'s Diluted EPS (TTM)?
Ardelyx, Inc.'s Diluted EPS (TTM) is -0.22, based on as-reported figures from SEC (XBRL) filings.
What is Ardelyx, Inc.'s EBITDA Margin?
Ardelyx, Inc.'s EBITDA Margin is -7.1%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · ARDXAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues
Total revenues
YoY growth+23.8%+27.5%+7.8%+12.3%
Costs and operating expenses
Cost of sales
Research and development
Selling, general and administrative
Total costs and operating expenses
% of revenue110.3%134.7%118.8%92.2%
Loss from operations
% of revenue-10.3%-34.7%4.1%4.2%
Interest expense
Non-cash interest expense related to the sale of future royalties
Other income, net
Loss before provision for income taxes
Provision for income taxes
Net loss
% of revenue-13.8%-39.8%-0.3%-0.9%
Net loss per share of common stock - basic (in dollars per share)
Net loss per share of common stock - diluted (in dollars per share)